Kalinor-Retard P

Potassium Chloride, the active ingredient in Kalinor-Retard P, is an electrolyte supplement presented as an oral dosage form for oral use. It replaces potassium ions and corrects hypokalemia in patients with potassium loss or deficiency.

GNH USA supplies Kalinor-Retard P as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kalinor-Retard P, a potassium supplement, is used to correct potassium deficits in conditions that cause hypokalemia.

- Hypokalemia: restores normal serum potassium concentrations. - Potassium deficiency: prevents clinical complications associated with low potassium levels. - Cardiac arrhythmia risk: reduces the likelihood of rhythm disturbances caused by inadequate potassium.

Kalinor-Retard P may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Abdominal discomfort: cramping or pain in the abdomen. - Diarrhea: loose stools occurring after ingestion. - Vomiting: occasional expulsion of stomach contents. - Taste disturbance: metallic or salty taste perception. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium levels. - Cardiac arrhythmia: irregular heart rhythm potentially leading to serious events. - Muscle weakness: severe weakness affecting mobility. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Metabolic acidosis: imbalance in blood pH in rare cases. - Respiratory distress: shortness of breath in extreme hyperkalemia.

When prescribing Kalinor-Retard P, clinicians should consider several safety measures.

- Renal impairment: assess kidney function and adjust dose as needed. - Cardiac disease: monitor ECG and serum potassium closely. - Concomitant potassium‑sparing diuretics: avoid additive hyperkalemia risk. - ACE inhibitors or ARBs: increase monitoring of potassium levels. - Hyperkalemia: discontinue immediately if serum potassium exceeds safe limits. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Potassium chloride can interact with several medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - ACE inhibitors: may cause excessive potassium accumulation. - Angiotensin receptor blockers: increase risk of hyperkalemia. - Potassium‑sparing diuretics: additive potassium load. - NSAIDs: reduce renal potassium excretion. - Trimethoprim: potentiates hyperkalemia.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of toxicity with high potassium. - Beta‑blockers: may mask symptoms of hyperkalemia. - Certain antibiotics (e.g., penicillins): can affect renal handling of potassium. - Insulin: may shift potassium intracellularly, altering serum levels. - Glucocorticoids: influence potassium balance.